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Abstract 
Radiotherapy is an important treatment option for many human cancers. Current 
research is investigating the use of molecular targeted drugs in order to improve 
responses to radiotherapy in various cancers. The cellular response to irradiation 
is driven by both direct DNA damage in the targeted cell and intercellular 
signalling leading to a broad range of bystander effects.  
This study aims to elucidate radiation-induced DNA damage response signalling 
in bystander cells and to identify potential molecular targets to modulate the 
radiation induced bystander response in a therapeutic setting.  
Stalled replication forks in T98G bystander cells were visualised via 
bromodeoxyuridine (BrdU) nuclear foci detection at sites of single stranded DNA. 
γH2AX co-localised with these BrdU foci. BRCA1 and FANCD2 foci formed in 
T98G bystander cells. Using ATR mutant F02-98 hTERT and ATM deficient 
GM05849 fibroblasts it could be shown that ATR but not ATM was required for 
the recruitment of FANCD2 to sites of replication associated DNA damage in 
bystander cells whereas BRCA1 bystander foci were ATM-dependent. Phospho-
Chk1 foci formation was observed in T98G bystander cells. Clonogenic survival 
assays showed moderate radiosensitisation of directly irradiated cells by the 
Chk1 inhibitor UCN-01 but increased radioresistance of bystander cells.  
This study identifies BRCA1, FANCD2 and Chk1 as potential targets for the 
modulation of radiation response in bystander cells. It adds to our understanding 
of the key molecular events propagating out-of-field effects of radiation and 
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provides a rationale for the development of novel molecular targeted drugs for 
radiotherapy optimisation. 
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1. Introduction 
Radiotherapy is a main treatment option for cancer patients, often combined with 
surgery and chemotherapy. Direct effects of radiation and their modulation for the 
benefit of treatment outcome (e.g. fractionation) have been extensively studied 
and this has led to much improved survival rates. In the last decade, radiation-
induced non-targeted bystander responses have increasingly been a focus of 
research, and may have significant potential for radiotherapy treatment 
optimisation [1-3]. Radiation induced non-targeted effects have been reported for 
a range of biological endpoints [4-9] including the induction of the DNA damage 
marker γH2AX [10-15].   
Most recently, ataxia-telangiectasia and Rad3-related (ATR) has been identified 
as a central player within the bystander signalling cascade that is responsible for 
H2AX phosphorylation. The ataxia-telangiectasia mutated (ATM) protein was 
found to be activated downstream of ATR [16] and ATR-mediated, S-phase 
dependent γH2AX and 53BP1 foci induction was observed [11]. These 
observations support the hypothesis of an accumulation of replication-associated 
DNA damage in bystander cells. DNA replication fork stalling can be caused by 
DNA damage through reactive oxygen or nitrogen species which are thought to 
play a central role in DNA damage induction in bystander cells. ATR is involved 
in the recognition of stalled replication forks, failure to stabilise them results in 
their collapse and ultimately in genetic instability (reviewed in [17]). The report of 
S-phase specific DNA damage recognised through an ATR and H2AX dependent 
mechanism in bystander cells strongly suggests the subsequent activation of the 
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Fanconi Anaemia (FA)/BRCA network which is a key pathway in the homologous 
recombination-dependent resolution of stalled replication and regulation of the 
intra-S-phase cell cycle checkpoint [18-20].  Phosphorylation of FANCD2 by 
either ATR or ATM is required for the induction of an intra-S-phase arrest. FA 
core proteins, ATR and RPA1 [21] are required for the ubiquitination of the 
FANCD2 protein in S-phase, a modification that is prerequisite for the 
accumulation at sites of DNA damage to form microscopically visible nuclear foci 
which associate with BRCA1, BRCA2 and RAD51. γH2AX in connection with 
BRCA1 recruits FANCD2 to chromatin at stalled replication forks [22] suggesting 
that H2AX is functionally linked to the FA/BRCA pathway to resolve stalled 
replication forks and prevent chromosome instability. 
The cell cycle checkpoint kinase Chk1 is regulated by ATR and is involved in the 
activation of the FA/BRCA pathway through phosphorylation of FANCE [23]. The 
G(2)/M [24] and S-phase DNA damage checkpoints require Chk1 activation [25].  
The FA/BRCA DNA repair pathway is frequently affected in breast cancer where 
BRCA1 or BRCA2 mutations can be found in approximately 10% of cases. 
Epigenetic silencing of BRCA1 occurs in 13% of breast cancers, 6% of cervical 
cancers and 4% of non-small-cell lung cancers. FANCF methylation is found in 
30% of cervical cancer, 14% of squamous cell head and neck cancers, 6.7% of 
germ cell tumours of testis, and 15% of non-small-cell lung cancers [26]. 
This study investigates the hypothesis of an activation of the FA/BRCA network 
in the radiation-induced bystander response at sites of stalled replication 
promoting both DNA repair by homologous recombination and intra-S-phase 
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checkpoint activation in bystander cells which is supported by our previous report 
of an S-phase restricted, ATR dependent formation of γH2AX and 53BP1 foci in 
bystander cells [11,16]. 
 
2. Materials and Methods 
2.1 Cell Culture and irradiations 
T98G glioma cells and GM05849 ATM deficient fibroblasts were cultured in RPMI 
1640 medium (Cambrex, Verviers, Belgium) supplemented with 10 % FBS (PAA, 
Pasching, Austria), 2 mM L-glutamine, 100 units/ml penicillin and 100 µg/ml 
streptomycin (all Cambrex, Verviers, Belgium). ATR mutated Seckel cells 
(F02/98 hTERT) and 48BR hTERT fibroblasts were cultured in MEM medium 
supplemented with 15 % FBS (PAA, Pasching, Austria), 2 mM L-glutamine, 100 
units/ml penicillin, 100 µg/ml streptomycin (all Cambrex, Verviers, Belgium) and 
0.4 µg / ml puromycin (Sigma, Poole, UK). All cells were incubated at 37C, 5 % 
CO2. For all experiments sub-confluent cell cultures were used. 
For medium transfer experiments cells were seeded on 22 x 22 mm2 coverslips 
placed in 6-well tissue culture dishes and treated with filtered medium obtained 
from T98G cells, which had been irradiated with 2 Gy of X-rays (Pantak, X-ray 
set, 240KV) at 37C. Following 30 min incubation the medium was taken off and 
filtered using a 0.45 µm syringe filter. The recipient cells were incubated with the 
conditioned medium at 37C, 5 % CO2 for 24 h followed by fixation and 
immunocytochemistry. Sham-treated cells were used as controls. For direct 
irradiations, cells were seeded on 22 x 22 mm2 coverslips placed in 6-well tissue 
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culture dishes and irradiated in cell culture medium at 37C with 1 and/or 5 Gy of 
X-rays (Pantak, X-ray set, 240KV) to induce similar BRCA1 and FANCD2 foci 
yields as those observed in bystander cells. Cells were incubated at 37C, 5 % 
CO2 for 4 h after direct radiation before fixation and 
immunocytochemistry.Caffeine (Sigma, Poole, UK) was used at a concentration 
of 1 mM which has been demonstrated and is being widely used to inhibit ATR 
and ATM [27-29]. The specific ATM inhibitor (ATMi) Ku55933 was used at a 
concentration of 10 µM. 
 
2.2 Bromodeoxyuridine labelling of DNA 
In order to visualise stalled replication forks in bystander cells, sub-confluent 
T98G cells were labelled with bromodeoxyuridine (BrdU) for 21 h, treated  with 
conditioned medium from irradiated cells for 3 h, then stained for BrdU nuclear 
foci (rat anti-BrdU, Cancer Research UK) applying a protocol without prior DNA 
denaturation [30] which relies on the recognition of single stranded, BrdU-
labelled DNA at sites of replication fork stalling. For γH2AX co-localisation with 
BrdU foci, the BrdU staining protocol was combined with the γH2AX staining 
protocol described below. 
A routine BrdU pulse labelling method was used to determine the fraction of 
actively replicating cells in control and bystander cell cultures treated with 
conditioned medium from 2 Gy-irradiated cells. 20 μM BrdU was added for 15 
min prior to ethanol fixation at -20ºC overnight. Following treatment with 2 M 
hydrochloric acid for 15 min at room temperature and neutralisation with 0.1M 
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sodium borate buffer, samples were washed in 0.5% Triton X100 in PBS, 
blocked in 3% foetal calf serum in PBS for 30 min, incubated with anti-BrdU 
antibody, washed in 0.1% Triton X 100 in PBS, incubated in Alexa Fluor 488-
conjugated secondary antibody (Molecular Probes, Leiden, The Netherlands) for 
30 min, washed in PBS and resuspended in propidium iodide/RNAse in PBS. 
Flow cytometry was performed using a Becton Dickinson FACScan and the 
fraction of BrdU-positive and -negative cells was determined using CellQuest 
software (Becton Dickinson).    
 
2.3 Immunocytochemistry 
For immunocytochemistry, cells grown on coverslips were fixed for 15 min with 4 
% paraformaldehyde, permeabilized with 0.5 % Triton-X 100 (both Sigma, Poole, 
UK) and blocked with 3 % FBS (PAA, Pasching, Austria) in PBS for 30 min at 
room temperature. Incubation with a primary antibody specific for H2AX p139S  
(Upstate, Chandlers Ford, UK), 53BP1 (Novus Biologicals, Littleton, CO, USA), 
BRCA1 (Oncogene, Cambridge, MA, USA), phospho-Chk1 (p348S; (Santa Cruz 
Biotechnology), BRCA1 (Oncogene Research Products; Ab-1) or FANCD2 
(Santa Cruz Biotechnology; sc28194) for 1 h at room temperature was followed 
by three washes of 10 min each in PBS/3% FBS and incubation with a matching 
Alexa Fluor 488 or 568 conjugated secondary antibody (Molecular Probes, 
Leiden, The Netherlands). DAPI-stained coverslips were mounted onto glass 
slides using Vectashield mounting medium (Vector Laboratories, Burlingame, 
CA) and the edges were sealed with clear nail varnish. A fluorescence 
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microscope was used for imaging and analysis (Zeiss, Welwyn Garden City, UK). 
Foci were scored by eye in all cells visible in each field of view. Average foci per 
cell and distribution of foci levels in the analysed cell population were calculated 
using Microsoft Excel. For the calculation of induced foci per cell, background 
foci numbers in untreated control cells were subtracted. 
 
2.4 Western Blot 
Cells were lysed in buffer (1% Igepal, 0.1% SDS, 0.05% sodium deoxycholate, 1 
protease inhibitor tablet and 1 PhosSTOP tablet (Roche, UK)) and protein 
concentration determined using the BCA assay (Pierce, UK) according to 
manufacturer‟s instructions. Samples were then subject to SDS-PAGE 
electrophoresis using the XCell SureLock Mini-Cell system (Invitrogen, UK), 
transferred onto nitrocellulous membranes (Millipore, UK), blocked for 1h in 3% 
skim milk blocking solution and probed accordingly. Antibody binding was 
detected using Supersignal West Pico or Femto Chemiluminescent substrate 
(Pierce, UK) according to manufacturer‟s instructions. Antibodies: anti- phospho 
Chk1 S345 diluted 1:500 (Cell Signalling, UK), anti-BRCA1 diluted 1:500 (Santa 
Cruz) and anti-β Actin diluted 1:2500 (Sigma, UK). 
 
2.5 Clonogenic Assay 
500 cells were seeded in each T25 tissue culture flask containing filtered medium 
derived from irradiated (2 Gy, X-rays) or sham-irradiated cells, and incubated for 
10 – 14 days at 37C, 5 % CO2. For experiments involving direct irradiation, 
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individual radiation doses were 0, 1, 2 and 5 Gy, with 500, 1000, 2000 and 5000 
cells seeded per flask, respectively. Flasks were stained with crystal violet 
staining solution, and individual colonies were counted. Average surviving 
fractions and standard errors (SEM) of 2 - 4 independent experiments performed 
in triplicates were calculated. The Chk1 inhibitor UCN-01 (7-
hydroxystauosporine) [31,32] was added to the culture medium at a final 
concentration of 10 nM 15 min prior to direct irradiation, or was added into the 
conditioned medium prior to transfer to recipient cells for bystander experiments.  
 
2.6 Data analysis 
Average foci numbers per cell, average survival fractions and standard errors 
were calculated using Microsoft Excel for Windows 2003 or 2010. The 
significance of reported findings was tested with a t-test comparing treated 
samples with their sham treated controls. Significance levels are provided in the 
text.  
Colocalisation analysis of BrdU and γH2AX foci was analysed with ImageJ 
software using Pearson correlation coefficients [33] and Costes‟ spatial statistics 
method [34]. 
3. Results 
3. 1 Stalled replication forks in bystander cells 
On the basis of published cell cycle distribution data of bystander cells and the S-
phase specificity of bystander foci formation [11,16] we postulated that γH2AX 
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and 53BP1 foci form at sites of stalled replication forks during S phase in 
bystander cells. To test this hypothesis, T98G glioma cells were cultured in BrdU-
containing medium for 21 h resulting in overall labelling of DNA during one cycle 
of DNA replication followed by incubation with filtered conditioned medium 
derived from irradiated T98G cells for 3 h. Stalled replication forks that expose 
short patches of single stranded, BrdU-labelled DNA were detected by anti-BrdU 
immunofluorescence microscopy and appeared as nuclear foci. Treatment with 
20 μM hydroxyurea for 3 h was included as a positive control. 
Immunofluorescence co-staining with a γH2AX specific antibody confirmed co-
localisation of BrdU foci at sites of stalled replication with γH2AX foci in 
bystander cells (Figure 1A), with a mean Pearson correlation coefficient of 0.85 
and significant correlation in all 20 analysed cells, according to Costes‟ spatial 
statistics method. Additional representative images are included in  
Supplementary Figure S1. Formation of both BrdU foci and co-localising γH2AX 
foci were inhibited by the ROS scavenger DMSO and by Filipin, a disruptor of 
lipid rafts in the cell membrane and inhibitor of membrane signalling (Figure 1B). 
Additional representative images are included in  Supplementary Figure S1. 
These findings confirm a role for ROS and membrane signalling in the induction 
of oxidative DNA damage in non-targeted cells.  
Replication stalling at sites of oxidative DNA damage in non-targeted cells can be 
expected to activate the intra-S phase checkpoint and slow down replication 
progression, resulting in a larger S phase fraction in bystander cells compared to 
untreated cells. To test this hypothesis, control and bystander cell cultures were 
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pulse-labelled with BrdU and the fraction of BrdU-positive cells determined using 
flow cytometry. Figure 1C shows that the percentage of BrdU-positive cells 
increases significantly in T98G (p=0.01) and 48BR hTERT bystander cells 
(p=0.05), compared to controls. In contrast, no significant increase was detected 
in ATR-deficient FO2/98 hTERT and ATM-deficient GM05849 human fibroblasts. 
Figure 1D shows the persistent increase of γH2AX foci in cultures of bystander 
T98G cells over a period of 24 h. 
 
3.2 FANCD2 and BRCA1 foci induction in bystander cells 
Immunostaining for BRCA1 and FANCD2 was performed to determine the 
involvement of the BRCA/FA network in bystander signalling.  
Directly irradiated T98G cells received an X-ray dose of 5 Gy and were 
subsequently stained for BRCA1 nuclear foci after 4 h incubation time. For the 
detection of BRCA1 bystander foci, cells were treated for 24 h with filtered 
medium derived from T98G cells irradiated with 2 Gy of X-rays (Figure 2A; see 
Supplementary Figure S2 for additional representative immunofluorescence 
microscopy images). Bystander cells showed a significant induction of BRCA1 
foci above background level (p=0.02, Figure 2C) although the fraction of cells 
without any foci remained at control level (Figure 2B). This finding is consistent 
with the S-phase dependence of bystander foci formation, as cells without foci 
are known to be mostly in the G1 phase of the cell cycle [11,16] . In contrast, 
high numbers of nuclear BRCA1 foci were induced in  all directly irradiated cells, 
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without any sign of a „resistent‟ subpopulation (Figure 2B). In this context it 
should be noted that the T98G control cultures analysed here contained 42±4 % 
S phase cells (BrdU-positive following pulse-labelling for 15 min), rising to 53±4 
% in bystander cells, measured using flow cytometry (raw data not shown).  
Western blot analysis of lysates from T98G cells treated with conditioned 
medium for 30 min or 4 h demonstrated a 2-3-fold increase of BRCA1 protein 
compared with control cells (p=0.04, Figure 2D,E).  Cells irradiated directly with 2 
Gy were included as a positive control in the experiment. Induction of  FANCD2 
foci (Figure 3A & B, see also Supplementary Figure S2 for additional 
representative immunofluorescence microscopy images) was detected both in 
directly irradiated and bystander cells, but only in  a fraction of the cells (Figure 
3B), which are most likely S-phase cells as FANCD2 nuclear foci are known to 
accumulate at stalled replication forks [22].  
Comparison of induced BRCA1 and FANCD2 foci in directly irradiated and 
bystander cells with γH2AX foci induction (Figure 3C) revealed a similar pattern 
of BRCA1 and γH2AX foci induction in cells directly irradiated with 5 Gy with an 
average of 23 and 25 induced foci per cell at 4 h after irradiation, whereas 
FANCD2 foci induction was on average 3.9 foci per cell. In bystander cells, 
BRCA1, FANCD2 and γH2AX foci induction was at a similar level with 2.4, 2.1 
and 3.6 induced foci per cell after 24 h of incubation with conditioned medium. 
Supplementary figure 4 (S4) shows the average number of foci per cell in foci-
containing cells only versus the whole cell population for p-Chk1, FANCD2, 
BRCA1 and γH2AX. These observations, taken together with the evident S-
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phase dependency of bystander foci induction which has previously been 
addressed in greater detail [11,16], support the hypothesis of an S-phase 
dependent bystander DNA damage response involving γH2AX, BRCA1 and 
FANCD2. 
 
3.3 BRCA1 and FANCD2 foci in ATR/ATM mutant cell lines, ATM-
inhibited and caffeine treated cells 
The reduction in clonogenic survival of bystander cells depends on ATR function 
and subsequent ATM activation [16] whereas bystander γH2AX foci induction 
requires ATR but not ATM [11]. To determine whether ATR and/or ATM are 
involved in the activation of the BRCA/FA network in bystander cells, ATR mutant 
F02-98 hTERT cells, ATM deficient GM05849 cells and ATMi or caffeine treated 
T98G cells were treated with conditioned medium derived from irradiated T98G 
cells and analysed for the induction of BRCA1 and FANCD2 foci (Figure 4A and 
4B) in comparison to T98G cells.  
FANCD2 bystander foci were detected in T98G (p<0.01), ATMi-treated and ATM- 
deficient GM05849 cells (p<0.01) but not in ATR mutated F02-98 hTERT cells 
and T98G cells treated with the ATR/ATM inhibitor caffeine. This indicates that 
ATR, but not ATM, is required for the recruitment of FANCD2 to sites of 
replication associated DNA damage in bystander cells. 
BRCA1 bystander foci were induced in T98G cells (p=0.02) but not in ATR 
mutated F02-98 hTERT, ATM deficient GM05849 or ATMi or caffeine treated 
T98G cells. These results suggest an essential role for ATM in the formation of 
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nuclear BRCA1 foci in bystander cells. As shown previously [16], the activation of 
ATM in bystander cells depends on functional ATR. Therefore, the inactivation of 
either ATR or ATM prevents the formation of BRCA1 nuclear foci in bystander 
cells. 
3.4 Phosphorylation of Chk1 in bystander cells and inhibition of a 
clonogenic bystander effect by the Chk1 inhibitor UCN-01 
Chk1 is a main downstream target of ATR and is involved in the activation of the 
BRCA/FA pathway [23]. Therefore, we tested the hypothesis of bystander Chk1 
activation which could provide a functional link between activation of ATR and 
BRCA/FA in bystander cells. Cells were treated for 24 h with filtered medium 
derived from 2 Gy X-irradiated T98G cells and immunostained for phospho-Chk1 
(p348S). Significantly increased phospho-Chk-1 foci formation was observed in 
T98G bystander cells (p<0.01, Figure 5A,B; see Supplementary Figure S3 for 
additional representative immunofluorescence microscopy images).  This was 
confirmed by Western blot analysis of protein lysate received from T98G cells 
treated for 30 min with filtered medium from irradiated cells (p=0.07). Lysate from 
cells irradiated directly with 5 Gy was included in this experiment as a positive 
control (Figure 5C,D). 
In order to test the functional importance of Chk1 in bystander responses, T98G 
cells were treated with the Chk1 inhibitor UCN-01 one hour prior to radiation and 
during subsequent incubation for colony formation in a clonogenic assay. A 
concentration of 10 nM resulted in a moderate radiosensitisation of T98G cells 
(p<0.05, Figure 6A). Bystander cells were treated with medium derived from 
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T98G cells treated with 10 nM UCN-01 and irradiated with 2 Gy. Whereas sham-
treated controls showed a significant reduction of the clonogenic survival of 
bystander cells (p<0.05), UCN-01-treated cultures were protected and showed 
only a minor non-significant bystander effect (Figure 6B). In T98G cells, higher 
doses of UCN-01 were toxic and could therefore not be tested for a further 
increase of the effect.  
 
4. Discussion 
This study aims to further clarify the DNA damage response network in bystander 
cells and to identify potential targets for novel molecular inhibitors. We have 
previously shown the S-phase restricted induction of γH2AX nuclear foci in an 
ATR dependent manner and the activation of ATM downstream of ATR in 
bystander cells [11,16]. Over the past few years, a novel FA/BRCA DNA damage 
response pathway has been uncovered which is a key pathway in the resolution 
of stalled replication and regulation of the intra-S-phase cell cycle checkpoint 
[20]. Functional loss of members of this pathway is linked to genomic instability 
[35].  
The DNA damage response during DNA replication in S-phase includes an ATM 
/ ATR mediated intra-S-phase checkpoint which suppresses DNA replication in 
response to DNA damage and also involves Chk1. Stabilisation and restarting of 
stalled replication forks involves proteins related to homologous recombination 
(HR) like Rad51 and various other proteins including RPA, ATR, 53BP1, BLM, 
γH2AX and BRCA1 (reviewed in [17]). 
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This study demonstrates the accumulation of stalled replication forks in 
bystander cells and their co-localisation with γH2AX foci. As bystander cells 
show an ATR- and ATM-dependent intra-S-phase arrest, it is important to note 
that bystander foci induction in S-phase cells may cause a further increase in 
overall foci numbers through subsequent accumulation of cells in S phase. 
However, full characterisation of such a response would require complex, long-
term time-lapse microscopy studies of foci formation in a bystander cell 
population.  
Bystander cells show the induction of FANCD2 and BRCA1 nuclear foci which 
are central proteins of the FA/BRCA DNA damage response network. Whilst the 
induction of bystander FANCD2 foci is ATR dependent but independent of ATM, 
the induction of BRCA1 bystander foci requires both ATR and ATM function. In 
this context, the question arises whether further molecules are involved as 
intermediaries in this pathway activation, given the complexity of the FA DNA 
repair network that has been uncovered in recent years [18-23,56]. Future 
studies are required as this is beyond the scope of this current study. 
While this study does not directly demonstrate that FANCD2 bystander foci form 
in S-phase cells, there is a strong line of argumentation from our previously 
published bystander studies and this current study to support this interpretation: 
(i) It has been thoroughly demonstrated that γH2AX foci are formed in S-phase 
cells via co-staining with CENP-F [11]; (ii) γH2AX foci co-localise with BrdU foci, 
highlighting replication fork stalling; (iii) γH2AX foci co-localise with BRCA1, ATR 
 18 
and ATM foci in bystander cells [16]; (iv) FANCD2 and γH2AX foci co-localise in 
bystander cells (Supplementary Figure 5).  
Interestingly, a recent study by Redon et al. suggests that malignant tumours 
induce a DNA damage response in proliferating distant tissue similar to the DNA 
damage response in the proposed bystander model  [36,37]. 
A previous study has demonstrated that the bystander effect observed in a co-
culture of targeted and non-targeted cells persists for at least 24 h following 
irradiation, using γH2AX foci induction in T98G cells as experimental system 
(Figure 3 in [11]). In this study, a persistent increase of γH2AX bystander foci for 
at least 24 h has also been confirmed for medium transfer experiments. This 
observation is supported by two independent reports by Facoetti et al. [38] and 
Zhang et al. [39] who also report a persistent bystander response in medium 
transfer experiments involving different endpoints than gamma-H2AX foci 
formation. However, no data have been obtained yet on the dose dependence of 
bystander foci induction. Yet, based on the general observation of dose-
independent bystander effects (e.g. Figure 4 from [4]) one would not expect to 
see a difference for conditioned medium obtained from cells exposed to different 
doses.  
The nature of the signal triggering a DNA damage response in non-targeted cells 
is still not entirely clear. Subnuclear foci of γH2AX and 53BP1 are well known to 
be associated with DNA double-strand breaks but their formation in bystander 
cells likely reflects only a secondary event triggered by stalled replication forks 
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rather than prompt “two-ended” DSBs. These stalled replication forks have been 
postulated to be a consequence of an accumulation of ROS leading to DNA 
damage, including base damage which accumulates in S-phase leading to 
replication fork stalling and secondary production of DSBs and chromosomal 
aberrations [40]. Increasing ROS levels following treatment with conditioned 
medium from irradiated cells have previously been reported [41]. The results 
presented suggest that bystander signals act in a similar manner as inter-strand 
crosslinks [42], ultraviolet light-induced damage [43], and human papillomavirus 
type 16 E7 oncoprotein-mediated replication stress [44]. All these factors activate 
the FA/BRCA pathway and may not directly induce DSBs but rather lead to 
secondary DNA breaks that form during replication, for example when the 
replication fork encounters an unrepaired single-strand break.  Such “one-ended” 
breaks are normally repaired via homologous recombination-dependent 
processes. The previous observation that sister chromatid exchanges are 
induced in bystander cells [45] in a homologous recombination-dependent 
manner [46] is consistent with this concept. 
A central role for Chk1 in the activation of the BRCA/FA network has been 
reported previously [23]. Our results show an activation of Chk1 in the radiation-
induced bystander DNA damage response and suggest the suitability of Chk1 as 
a further potential target to differentially modulate radiation effects on directly 
irradiated and non-targeted bystander cells. In a similar manner to the Chk1 
response reported here, where the Chk1 inhibitor UCN-1 acted as a 
radiosensitizer in directly radiated cells but increased survival in bystander cells 
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(Figure 6), ATR and ATM inhibitors have previously been demonstrated to 
differentially modulate targeted and bystander responses for the endpoint of 
clonogenic cell survival [16]. It is thought that inhibition of the repair proteins 
involved in the bystander response may increase the survival of damaged cells 
which may otherwise have undergone cell cycle arrest or apoptosis. However, 
this hypothesis has not been tested yet and will be the subject of future studies.  
The FA/BRCA pathway is affected in many human tumours including bladder 
[47], breast [48] and cervical [49] cancer either through gene mutations or 
epigenetic changes, and inherited mutation in either BRCA1 or BRCA2 causes a 
hereditary breast and ovarian cancer syndrome. Many of these cancers are 
treated with radiotherapy. Investigating the role of this pathway in the response to 
radiation-induced DNA damage is therefore important for treatment optimisation. 
Especially pathways targeted by novel molecular inhibitors (e.g. PARP inhibitors 
in BRCA mutated tumours [50], ATM inhibitors or Chk1 inhibitors) with the 
potential for combined radiotherapy [51] need to be investigated regarding their 
effects on directly irradiated and bystander cells. Furthermore, increased clinical 
as well as cellular radiosensitivity has been reported for some but not all patients 
with inherited defects in the FA/BRCA pathway [52-59], adding to the complexity 
of radiotherapy treatment optimisation.  
Limiting the radiation induced genomic damage of normal cells, which may 
further lead to cancer formation is key in the field of radiation protection. 
Furthermore, radiation induced bystander cells are at risk for late genomic 
instability, which is associated with many cancers. Further studies on genomic 
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instability in bystander cells will be needed to understand the possible 
mechanisms of secondary cancers after radiation exposure. 
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Figure Legends 
 
Figure 1: Immunofluorescence microscopic visualisation of stalled replication 
forks in bystander T98G cells. (A) Co-localisation of BrdU foci with γH2AX 
nuclear foci at sites of stalled replication in bystander cells and cells treated with 
20 μM hydroxyurea; (B) Inhibition of BrdU and γH2AX nuclear foci in bystander 
cells by Filipin and DMSO. (C) Increase in the fraction of BrdU-positive cells 
detected by flow cytometry following pulse-labelling of bystander and 
corresponding control cultures. Bars show average values from 3 independent 
experiments for each cell line. Error bars show the associated standard errors. 
(D) Persistent increase of bystander gamma-H2AX foci numbers in T98G cell 
cultures treated for 0.5, 4 or 24 h with conditioned medium. Bars show average 
values from 2-6 independent experiments for each time point. Error bars show 
the associated standard errors. 
 
Figure 2: BRCA1 induction in directly irradiated and bystander T98G cells. (A) 
Anti-BRCA1 immunofluorescence microscopic images of control, bystander and 
directly irradiated cells. Nuclei were counterstained with DAPI. (B) Distribution 
and (C) average values of BRCA1 foci in control, bystander and directly 
irradiated cells.  Foci data were collected from a total of 204 control and 204 
bystander cells in four independent experiments and 53 1 Gy and 39 5 Gy-
irradiated cells in one experiment.  (D) Western blot analysis for BRCA1 and β-
actin expression. Densitometric intensity profiles are shown for control (thin line), 
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2 Gy-irradiated (dashed line) and bystander samples (thick line). Densitometry 
readings are quantified on a linear scale. (E) Fold change relative to unirradiated 
controls in BRCA1 expression levels of irradiated and bystander samples 
following normalisation to β-actin levels. Error bars show the standard errors. 
 
Figure 3: (A&B) Induction of FANCD2 foci in directly 5 Gy-irradiated and 
bystander T98G cells.  The diagram shows the distribution of foci.  Foci data 
were collected from a total of 78 control and 98 bystander cells in two 
independent experiments and 68 5 Gy-irradiated cells in one experiment. Error 
bars show the standard errors (C) Bystander and 5 Gy-induced γH2AX, FANCD2 
and BRCA1 foci in T98G cells. Foci counts in control samples were subtracted. 
Bars represent average induced foci per cell; error bars show SEM from 2-5 
experiments. 
 
Figure 4: Bystander BRCA1 (A) and FANCD2 foci (B) in T98G cells, T98G 
treated with the specific ATM inhibitor (ATMi) KU55933 at 10 µM or the 
ATR/ATM inhibitor caffeine at 1 mM, as well as in GM05849 AT cells and in ATR 
mutated FO2-98 hTERT cells. Foci counts in control samples were subtracted. 
Bars represent average induced foci per cell; error bars show SEM from 3-5 
experiments.  
 
Figure 5: Phospho-Chk1 foci induction in bystander T98G cells. (B) Bars 
represent average p-Chk1 foci per cell; error bars show SEM from 2 
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experiments. (C) Western blot analysis of Chk1 phosphorylation and  β-actin 
expression. Densitometric intensity profiles are shown for control (thin line), 5 Gy-
irradiated (dashed line) and bystander samples (thick line). Densitometry 
readings are quantified on a linear scale. (D) Fold change relative to unirradiated 
controls in pChk1 expression levels of irradiated and bystander samples 
following normalisation to β-actin levels. Error bars show the standard errors. 
 
Figure 6: Clonogenic survival of directly irradiated (A) and bystander T98G cells 
(B) treated with 0 nM or 10 nM of Chk1 inhibitor UCN-01; error bars show SEM 
from 2-4 experiments. 
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Figure S1A.  Immunofluorescence microscopy of BrdU foci (red) and γH2AX foci (green) at sites of stalled replication in bystander cells. Samples were counter-stained with 
DAPI (blue). See Figure 1A for details. Each image is 162 µm wide. 
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Figure S1B.  Immunofluorescence microscopy of BrdU foci (red) and γH2AX foci (green) at sites of stalled replication in bystander cells treated with Filipin. Samples were 
counter-stained with DAPI (blue). See Figure 1B for details. Each image is 162 µm wide. 
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Figure S1C.  Immunofluorescence microscopy of BrdU foci (red) and γH2AX foci (green) at sites of stalled replication in bystander cells treated with DMSO. Samples were 
counter-stained with DAPI (blue). See Figure 1B for details. Each image is 162 µm wide. 
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Figure S1D.  Immunofluorescence microscopy of BrdU foci (red) and γH2AX foci (green) at sites of stalled replication in untreated and Filipin-treated control cells. Samples were 
counter-stained with DAPI (blue). See Figure 1B for details. Each image is 162 µm wide. 
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Figure S1E.  Immunofluorescence microscopy of BrdU foci (red) and γH2AX foci (green) at sites of stalled replication in DMSO-treated control cells. Samples were 
counter-stained with DAPI (blue). See Figure 1B for details. Each image is 162 µm wide. 
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Figure S2A.  Co-immunofluorescence microscopy of FANCD2 foci (red) and BRCA1 foci (green) at sites of stalled replication in bystander cells. Samples were counter-stained 
with DAPI (blue). See Figures 2A and 3A for details. Each image is 97 µm wide. 
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Figure S2A, cont’d.  Co-immunofluorescence microscopy of FANCD2 foci (red) and BRCA1 foci (green) at sites of stalled replication in bystander cells. Samples were counter-
stained with DAPI (blue). See Figures 2A and 3A for details. Each image is 97 µm wide. 
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Figure S2B.  Co-immunofluorescence microscopy of FANCD2 foci (red) and γH2AX foci (green) at sites of stalled replication in bystander cells. Samples were counter-stained 
with DAPI (blue). Each image is 38 µm wide. 
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Figure S3.  Immunofluorescence microscopy of pChk1 foci (green) in bystander cells. Samples were counter-stained with DAPI (blue). See Figure 5A for 
details. Each image is 57 µm wide. 
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Figure S4. Average number of p-Chk1, FANCD2, BRCA1 and gamma-H2AX foci per 
T98G cell in foci-bearing cells only in control, 5 Gy-irradiated and bystander cell cultures 
treated with medium from 2 Gy-irradiated cells. Foci data were collected from a total of 
348 control, 333 bystander cells and 305 directly irradiated cells in two experiments. 
The analysis includes foci bearing cells only. Error bars show the standard errors.  
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Figure S5.  Immunofluorescence microscopy of FANCD2 foci (red) and γH2AX foci (green) in bystander cells. 
Samples were counter-stained with DAPI (blue).  
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